News

The study is the first of several under way on the pill, orforglipron, and raised hopes of an effective and easy-to-use treatment reaching a market dominated by weight-loss injections. Eli Lilly ...
Participants on the highest dose of the pill lost an average of 16 pounds, or nearly 8% of their body weight. This level of weight loss is consistent with the amount shed over the same period ...
It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions. The pill form could expand access and reduce costs compared with injectable GLP-1 drugs. The ...
Lilly said weight loss hadn’t plateaued at the time the study ended, suggesting that patients might lose more weight. The pill lowered blood sugar levels by an average of 1.3%. Ozempic lowered ...